FDA Panel Breathes New Life Into Telavancin For Nosocomial Pneumonia
This article was originally published in The Pink Sheet Daily
Executive Summary
The Anti-Infective Drugs Advisory Committee votes 13-2 in favor of a limited indication for Theravance’s antibiotic, particularly for use in treating methicillin-resistant infections. The endorsement comes after a nearly four-year regulatory battle over the NDA.